Abstract
The Australian Cystic Fibrosis Data Registry is positioning itself as an exemplar of a rare disease registry for the future. While it continues to inform cystic fibrosis (CF) clinicians of patterns of CF disease and quality of care, its capability is increasing as a resource for further research into CF subpopulations, as a platform for clinical trials, and as an interface for patient experiences.
| Original language | English |
|---|---|
| Pages (from-to) | 721-723 |
| Number of pages | 3 |
| Journal | Internal Medicine Journal |
| Volume | 48 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 1 Jun 2018 |
Keywords
- clinical trial
- cystic fibrosis
- patient-reported outcome
- quality improvement
- registry
- research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver